Cytochrome bc1 Catalytic Subunit Rip1 Modulates Antifungal Tolerance in Candida auris
Authors:
Open Access
- 28 July 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
Abstract
Candida auris is an emerging fungal pathogen causing invasive infections in immunocompromised patients, with mortality rates reaching up to 60%. Pronounced drug resistance makes treatment failure common, and so does antifungal tolerance, a phenomenon enabling pathogen survival at supra-MIC concentrations without resistance mutations. Here, we uncover a mechanism of antifungal tolerance in C. auris engaging the mitochondrial cytochrome bc1 complex. Deletion of RIP1, a conserved catalytic complex subunit, does not significantly alter the susceptibility to caspofungin or voriconazole. However, rip1Δ mutants exhibit a marked reduction in antifungal tolerance across a wide range of supra-MIC concentrations. Transcriptomics reveals the dysregulation of multiple drug resistance and tolerance-related genes in the rip1Δ mutant, demonstrating a role for Rip1 in controlling antifungal susceptibility. Targeting cytochrome bc1 function with the fungal-specific inhibitor Inz-5 enhances antifungal action of both voriconazole and caspofungin. Additionally, ablation of RIP1 causes fitness defects, suggesting that cytochrome bc1 is a potential antifungal target against C. auris infections.Keywords
Funding Information
- Austrian Science Fund (Candidomics - P-33425)
- Austrian Science Fund (ChromFunVir - P-32582-B08)
- Austrian Science Fund (FWF-SFB70-08)
- Austrian Science Fund (TissueHome FWF-DOC32-B28)
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID Research Grant 2023)
- ASEAN-European Academic University Network (Bernd Rode Award 2024)
- ASEAN-European Academic University Network (Ernst Mach Grant)
- National Institutes of Health (R01AI182977)
This publication has 42 references indexed in Scilit:
- Candida auris skin tropism and antifungal resistance are mediated by carbonic anhydrase Nce103Nature Microbiology, 2025
- Accumulation of Trehalose 6-Phosphate in Candidozyma auris results in Decreased Echinocandin Resistance and ToleranceNature Communications, 2025
- Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida aurisNature Communications, 2025
- Acquired amphotericin B resistance leads to fitness trade-offs that can be mitigated by compensatory evolution in Candida aurisNature Microbiology, 2024
- Global incidence and mortality of severe fungal diseaseThe Lancet Infectious Diseases, 2024
- Forward and reverse genetic dissection of morphogenesis identifies filament-competent Candida auris strainsNature Communications, 2021
- clusterProfiler 4.0: A universal enrichment tool for interpreting omics dataThe Innovation, 2021
- Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemiaNature Communications, 2018
- A Fungal-Selective Cytochrome bc1 Inhibitor Impairs Virulence and Prevents the Evolution of Drug ResistanceCell Chemical Biology, 2016
- Defining the frontiers between antifungal resistance, tolerance and the concept of persistenceDrug Resistance Updates, 2015